Each year, drug-resistant microorganisms infect 2 million people and kill 23,000 patients. In order for physicians to be able to treat drug-resistant infections within an appropriate treatment window, the pathogen must first be detected and identified. Yet current clinical diagnosis can take 3-4 days to process, leaving patients without effective treatment while they wait. A novel gene amplification method, currently termed “SPIDR”, allows for a rapid assay to alleviate this wait time and quickly and accurately identify the pathogen at hand.
Hill, J., Beriwal, S., Chandra, I., Paul, V. K., Kapil, A., Singh, T., Wadowsky, R. M., Singh, V., Goyal, A., Jahnukainen, T., Johnson, J. R., Tarr, P. I., & Vats, A. (2008). Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Common Strains ofEscherichia coli. Journal of Clinical Microbiology, 46(8), 2800–2804. https://doi.org/10.1128/jcm.00152-08
Bista, B. R., Ishwad, C., Wadowsky, R. M., Manna, P., Randhawa, P. S., Gupta, G., Adhikari, M., Tyagi, R., Gasper, G., & Vats, A. (2007). Development of a Loop-Mediated Isothermal Amplification Assay for Rapid Detection of BK Virus. Journal of Clinical Microbiology, 45(5), 1581–1587. https://doi.org/10.1128/jcm.01024-06